Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Chrystyn

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 23, 2010
Aerodynamic characteristics of a dry powder inhaler at low inhalation flows using a mixing inlet with an Andersen Cascade ImpactorDinesh Kumar Nadarassan, Khaled H Assi, Henry Chrystyn
AAPS Pharmscitech|July 24, 2010
Evaluation of a nanoemulsion-based formulation for respiratory delivery of budesonide by nebulizersAmir Amani, Peter York, Henry Chrystyn, et al.
International Journal of Pharmaceutics|June 6, 2015
Effect of inhalation profile and throat geometry on predicted lung deposition of budesonide and formoterol (BF) in COPD: An in-vitro comparison of Spiromax with TurbuhalerHenry Chrystyn, Guilherme Safioti, Johan René Keegstra, et al.
British Journal of Clinical Pharmacology|February 4, 2012
Urinary pharmacokinetic methodology to determine the relative lung bioavailability of inhaled beclometasone dipropionateAmira S A Said, Lindsay P Harding, Henry Chrystyn
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 1, 2019
Real-life budesonide and formoterol dose emission from the medium and high strength fixed dosed combinations in a Spiromax® dry powder inhaler using inhalation profiles from patients with chronic obstructive pulmonary diseaseGolshan Bagherisadeghi, Henry Chrystyn, Mohamad Abadelah, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 9, 2002
Determination of gentamicin in urine samples after inhalation by reversed-phase high-performance liquid chromatography using pre-column derivatisation with o-phthalaldehydeAbdulsalam I Al-Amoud, Brian J Clark, Henry Chrystyn
Pharmaceutical Research|November 13, 2009
Factors affecting the stability of nanoemulsions--use of artificial neural networksAmir Amani, Peter York, Henry Chrystyn, et al.
Chest|April 3, 2007
The potential of a 2Tone Trainer to help patients use their metered-dose inhalersRaid A M Al-Showair, Stanley B Pearson, Henry Chrystyn
Journal of Pharmaceutical Sciences|July 17, 2007
Evaluation of an in vitro in vivo correlation for nebulizer delivery using artificial neural networksMarcel de Matas, Qun Shao, Victoria Louise Silkstone, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|September 10, 2015
Spiromax, a New Dry Powder Inhaler: Dose Consistency under Simulated Real-World ConditionsGiorgio Walter Canonica, Jan Arp, Johan René Keegstra, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 23, 2010
Aerodynamic characteristics of a dry powder inhaler at low inhalation flows using a mixing inlet with an Andersen Cascade ImpactorDinesh Kumar Nadarassan, Khaled H Assi, Henry Chrystyn
AAPS Pharmscitech|July 24, 2010
Evaluation of a nanoemulsion-based formulation for respiratory delivery of budesonide by nebulizersAmir Amani, Peter York, Henry Chrystyn, et al.
International Journal of Pharmaceutics|June 6, 2015
Effect of inhalation profile and throat geometry on predicted lung deposition of budesonide and formoterol (BF) in COPD: An in-vitro comparison of Spiromax with TurbuhalerHenry Chrystyn, Guilherme Safioti, Johan René Keegstra, et al.
British Journal of Clinical Pharmacology|February 4, 2012
Urinary pharmacokinetic methodology to determine the relative lung bioavailability of inhaled beclometasone dipropionateAmira S A Said, Lindsay P Harding, Henry Chrystyn
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 1, 2019
Real-life budesonide and formoterol dose emission from the medium and high strength fixed dosed combinations in a Spiromax® dry powder inhaler using inhalation profiles from patients with chronic obstructive pulmonary diseaseGolshan Bagherisadeghi, Henry Chrystyn, Mohamad Abadelah, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 9, 2002
Determination of gentamicin in urine samples after inhalation by reversed-phase high-performance liquid chromatography using pre-column derivatisation with o-phthalaldehydeAbdulsalam I Al-Amoud, Brian J Clark, Henry Chrystyn
Pharmaceutical Research|November 13, 2009
Factors affecting the stability of nanoemulsions--use of artificial neural networksAmir Amani, Peter York, Henry Chrystyn, et al.
Chest|April 3, 2007
The potential of a 2Tone Trainer to help patients use their metered-dose inhalersRaid A M Al-Showair, Stanley B Pearson, Henry Chrystyn
Journal of Pharmaceutical Sciences|July 17, 2007
Evaluation of an in vitro in vivo correlation for nebulizer delivery using artificial neural networksMarcel de Matas, Qun Shao, Victoria Louise Silkstone, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|September 10, 2015
Spiromax, a New Dry Powder Inhaler: Dose Consistency under Simulated Real-World ConditionsGiorgio Walter Canonica, Jan Arp, Johan René Keegstra, et al.
Pageof 9